Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panaccione

Showing results (221-230 of 652) with videos related to

Pageof 66
Sort By:
Journal of Crohn'S & Colitis|October 5, 2018
Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc AnalysisWilliam J Sandborn, Jean-Frédéric Colombel, Remo Panaccione, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 14, 2011
Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trialRemo Panaccione, Edward V Loftus, David Binion, et al.
Explore (New York, N.Y.)|July 2, 2021
Evaluation of an integrated yoga program in patients with inflammatory bowel disease: A pilot studySandeep Kaur, Adrijana D'Silva, Vidya Rajagopalan, et al.
Canadian Journal of Gastroenterology & Hepatology|July 23, 2016
Point of Care Ultrasound Accurately Distinguishes Inflammatory from Noninflammatory Disease in Patients Presenting with Abdominal Pain and DiarrheaKerri L Novak, Deepti Jacob, Gilaad G Kaplan, et al.
Journal of the Canadian Association of Gastroenterology|August 3, 2022
Cost-Effectiveness of Tight Control for Crohn's Disease With Adalimumab-Based Treatment: Economic Evaluation of the CALM Trial From a Canadian PerspectivePeter L Lakatos, Gilaad G Kaplan, Brian Bressler, et al.
Journal of Agricultural and Food Chemistry|June 22, 2006
Effects of ergot alkaloids on food preference and satiety in rabbits, as assessed with gene-knockout endophytes in perennial ryegrass (Lolium perenne)Daniel G Panaccione, Jessica R Cipoletti, Andrea B Sedlock, et al.
Journal of Patient-Reported Outcomes|April 1, 2022
Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel urgency in adultsMarla C Dubinsky, Peter M Irving, Remo Panaccione, et al.
Journal of Proteome Research|May 12, 2012
Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individualsRudolf Schicho, Rustem Shaykhutdinov, Jennifer Ngo, et al.
The American Journal of Gastroenterology|July 1, 2010
The inflammatory bowel diseases and ambient air pollution: a novel associationGilaad G Kaplan, James Hubbard, Joshua Korzenik, et al.
Annals of the Rheumatic Diseases|January 17, 2009
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseasesG R Burmester, P Mease, B A C Dijkmans, et al.
Pageof 66

Showing results (221-230 of 652) with videos related to

Sort By:
Pageof 66
Journal of Crohn'S & Colitis|October 5, 2018
Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc AnalysisWilliam J Sandborn, Jean-Frédéric Colombel, Remo Panaccione, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|September 14, 2011
Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trialRemo Panaccione, Edward V Loftus, David Binion, et al.
Explore (New York, N.Y.)|July 2, 2021
Evaluation of an integrated yoga program in patients with inflammatory bowel disease: A pilot studySandeep Kaur, Adrijana D'Silva, Vidya Rajagopalan, et al.
Canadian Journal of Gastroenterology & Hepatology|July 23, 2016
Point of Care Ultrasound Accurately Distinguishes Inflammatory from Noninflammatory Disease in Patients Presenting with Abdominal Pain and DiarrheaKerri L Novak, Deepti Jacob, Gilaad G Kaplan, et al.
Journal of the Canadian Association of Gastroenterology|August 3, 2022
Cost-Effectiveness of Tight Control for Crohn's Disease With Adalimumab-Based Treatment: Economic Evaluation of the CALM Trial From a Canadian PerspectivePeter L Lakatos, Gilaad G Kaplan, Brian Bressler, et al.
Journal of Agricultural and Food Chemistry|June 22, 2006
Effects of ergot alkaloids on food preference and satiety in rabbits, as assessed with gene-knockout endophytes in perennial ryegrass (Lolium perenne)Daniel G Panaccione, Jessica R Cipoletti, Andrea B Sedlock, et al.
Journal of Patient-Reported Outcomes|April 1, 2022
Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel urgency in adultsMarla C Dubinsky, Peter M Irving, Remo Panaccione, et al.
Journal of Proteome Research|May 12, 2012
Quantitative metabolomic profiling of serum, plasma, and urine by (1)H NMR spectroscopy discriminates between patients with inflammatory bowel disease and healthy individualsRudolf Schicho, Rustem Shaykhutdinov, Jennifer Ngo, et al.
The American Journal of Gastroenterology|July 1, 2010
The inflammatory bowel diseases and ambient air pollution: a novel associationGilaad G Kaplan, James Hubbard, Joshua Korzenik, et al.
Annals of the Rheumatic Diseases|January 17, 2009
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseasesG R Burmester, P Mease, B A C Dijkmans, et al.
Pageof 66